Ajamete Kaykas

Ajamete Kaykas, Chief eXploration Officer at Insitro, shares his expertise on harnessing AI for drug discovery. He discusses the innovative ClinML, CellML, and ChemML platforms that combine human data and cellular perturbations. Ajamete highlights the importance of integrating public datasets like UK Biobank with proprietary data. He addresses the gradual impact of AI in the field and emphasizes its role as an assistant to scientists. Finally, he advocates for cross-disciplinary training to foster the next generation of biologist-data scientists.